Spike RBD Antibody (1049349) [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # FAB11055K
Conjugate
Catalog #
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
Flow Cytometry, Immunocytochemistry
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Monoclonal Mouse IgG2B Clone # 1049349
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human embryonic kidney cell HEK293-derived SARS-CoV-2 Spike RBD
Val16-Pro681
Accession # YP_009724390.1
Val16-Pro681
Accession # YP_009724390.1
Specificity
Detects SARS-CoV-2 Spike RBD in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for Spike RBD Antibody (1049349) [DyLight 488]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Spike RBD
Long Name
Spike Receptor Binding Domain
Additional Spike RBD Products
Product Documents for Spike RBD Antibody (1049349) [DyLight 488]
Product Specific Notices for Spike RBD Antibody (1049349) [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...